Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors

JCO Precis Oncol. 2023 Mar:7:e2200547. doi: 10.1200/PO.22.00547.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anaplastic Lymphoma Kinase / genetics
  • Carcinoma, Non-Small-Cell Lung*
  • Evolution, Molecular
  • Glioma* / drug therapy
  • Glioma* / genetics
  • Humans
  • Infant
  • Lung Neoplasms*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Anaplastic Lymphoma Kinase
  • Protein Kinase Inhibitors
  • ALK protein, human